| Serial Number | 97446452 |
| Word Mark | LEGEND BIOTECH |
| Filing Date | Tuesday, June 7, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 23, 2024 |
| Registration Number | 7283305 |
| Registration Date | Tuesday, January 23, 2024 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 7, 2023 |
| Description of Mark | The mark consists of the wording "LEGEND" above the wording "BIOTECH," both in stylized form and to the right of a wavy line forming the letters "L" and "B". |
| Goods and Services | Pharmaceuticals and medical preparations for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical use; biological preparations for medical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; biological tissue cultures for medical purposes; chemical preparations for medical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; chemical preparations for pharmaceutical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; drugs for medical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; immunostimulants; medicines for human purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; pharmaceutical preparations, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; Pharmaceutical compositions for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; pharmaceuticals for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; stem cells for medical purposes; Injectable pharmaceuticals for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; anti-cancer drugs; Anti-cancer preparations; Compounds for treating cancer; Pharmaceutical preparations and substances for the treatment of cancer; Anti-cancer preparations from hormones and antagonists; Biopharmaceuticals for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Cell growth media for growing cells for medical use; Cells for medical use, Living cells for medical use; vaccine preparation; Medical diagnostic preparations |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Medical services; alternative medicine services; cultured cell bank services for medical transplantation; health care; health centre services; health counselling; health assessment services; hospital services; medical advice for individuals with disabilities; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; medical clinic services; medical treatment using cultured cells; preparation of prescriptions by pharmacists; therapy services, namely, immunotherapy, cell therapy, gene therapy, antibody therapy, radiation therapy, or chemotherapy; Medical services relating to the removal, treatment and processing of human cells; Providing cancer screening services; Medical services for the treatment of cancer; Medical analysis services for the diagnosis of cancer; Medical analysis services for cancer diagnosis and prognosis; Medical screening; provision of medical information; stem cell therapy services |
| Disclaimer with Predetermined Text | "BIOTECH" |
| Goods and Services | Scientific and technological services, namely, scientific research, analysis, and testing in the field of biotechnology and scientific research and design relating thereto; design and development of computer hardware and software; biological research; chemical analysis; chemical research; chemistry services namely research in the field of chemistry; Scientific research in the nature of conducting clinical trials for others; culturing of cells for scientific research purposes, for others; medical research; research and development of new products for others; scientific laboratory services; scientific research; technological research in the field of biotechnology; Cell separation technology research services; Cell separation research services; Cell culture services for scientific and research purposes, for others; Scientific services relating to the isolation and cultivation of human tissues and cells for scientific and research purposes; Scientific research for medical purposes in the area of cancerous diseases; Stem cell research services; Antibody research and development; Pharmaceutical research and development; Medical computer programming |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 16, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, November 30, 2018 |
| First Use In Commerce Date | Friday, November 30, 2018 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 16, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, November 30, 2018 |
| First Use In Commerce Date | Friday, November 30, 2018 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 16, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | Friday, November 30, 2018 |
| First Use In Commerce Date | Friday, November 30, 2018 |
| Party Name | Nanjing Legend Biotech Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Nanjing, Jiangsu 211100 CN |
| Party Name | Nanjing Legend Biotech Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Nanjing, Jiangsu 211100 CN |
| Party Name | Nanjing Legend Biotech Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Nanjing, Jiangsu 211100 CN |
| Event Date | Event Description |
| Tuesday, January 23, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, January 23, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, November 7, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 7, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 18, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, October 5, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, September 30, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, September 29, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, September 29, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, September 25, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, September 25, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, September 25, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, September 25, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, September 25, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, June 20, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Tuesday, June 20, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, March 29, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, March 29, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 29, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 22, 2023 | ASSIGNED TO EXAMINER |
| Friday, June 17, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, June 16, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 10, 2022 | NEW APPLICATION ENTERED |